[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![BullTradeFinder Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::2222635612.png) Gnotz (Bull) [@BullTradeFinder](/creator/twitter/BullTradeFinder) on x 103.5K followers
Created: 2025-07-17 15:03:54 UTC

$QNTM just submitted its patented MS drug for UK fast-track review. 

First-in-class therapy targeting demyelination with huge upside in a $30B+ market. 

Early mover in a massive space.

Communicated-Disclaimer



XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1945862028343537746/c:line.svg)

**Related Topics**
[$30b](/topic/$30b)
[$qntm](/topic/$qntm)

[Post Link](https://x.com/BullTradeFinder/status/1945862028343537746)